Patients With A High-Risk Common Type COVID-19 Pneumonia May Be the Optimal Time for Methylprednisolone Therapy: A Retrospective Cohort StudyLei Liu, Wei Zhang, Chun-Li Che et al.|SSRN Electronic Journal|2021Cited by 0